Medicines for Ulcerative Colitis: Their Kinds and Advantages

Medicines for Ulcerative Colitis: Their Kinds and Advantages

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD), similar to Crohn's disease. Although UC is a chronic condition with no known cure, gastroenterologists can prescribe various medications and treatments to manage symptoms.

One common treatment for UC is 5-aminosalicylic acid (5-ASA) drugs, such as mesalamine. These medications are anti-inflammatory and help reduce inflammation in the colon. Common side effects associated with 5-ASA drugs include gastrointestinal symptoms like nausea, abdominal pain, diarrhea, gas, bloating, and mild stomach discomfort. Other frequently reported side effects are headache, dizziness, general fatigue, weakness, and fever. These side effects are generally mild and well tolerated but can occasionally be more serious, requiring medical attention if symptoms such as severe abdominal pain, blood in stools, fever, or breathing difficulties occur.

Balsalazide, sold under the name Colazal, is another medication used to treat mild to moderate active signs of UC in people older than 5 years. It is a 5-ASA drug that works similarly to mesalamine.

Aminosalicylates, a type of anti-inflammatory medication, are also used to treat UC. Sulfasalazine, sold under the brand name Azulfidine, is an example of an aminosalicylate. Olsalazine is another medication used to help maintain remission in UC, especially for those who have an intolerance to sulfasalazine.

Corticosteroids, such as prednisone, are a well-established treatment for IBD and provide short-term relief of symptoms. However, they are not mentioned as a treatment for UC in this article. Corticosteroids can cause side effects such as greater susceptibility to infection, weakened bones, insomnia, high blood pressure, high blood sugar, mood swings, cataracts, growth of facial hair, growth issues in children, weight gain, and developing a round or moon-shaped face.

Immunomodulators, such as methotrexate, cyclosporine, azathioprine, 6-mercaptopurine, and tacrolimus, are drugs that target IBD inflammation by managing the body's immune system response. Methylprednisolone is a corticosteroid delivered through an enema, reducing inflammation and lowering the risk of side effects. Hydrocortisone acetate, administered as a rectal foam, helps deliver medication to the colon and rectum, also reducing inflammation.

Biologics, such as Tysabri (natalizumab) and Entyvio (vedolizumab), are a class of approved drugs that aim to target proteins that cause inflammation. They are integrin receptor antagonists and work by blocking the proteins that trigger inflammation. Other examples of biologics include Stelara (ustekinumab), an interleukin-12 and -23 antagonist. Potential side effects from biologics include a higher risk of infection, pain or itching at the injection site, allergic reactions, headache, fever, chills, rash, a potential for a higher risk of lymphoma, a potential for liver problems, skin problems, joint pain, and more.

JAK inhibitors, such as Xeljanz (tofacitinib) and upadacitinib (Rinvoq), are a new treatment for UC using small molecule compounds that break down in the gastrointestinal tract and target the immune system to reduce the response that triggers UC. However, they can also cause side effects such as upper respiratory tract infections, headache, diarrhea, shingles, blood clots, high cholesterol, and reactivated infections such as hepatitis B and C.

Over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) can help relieve joint pain or fever from UC, but should be used with caution due to the potential risk of causing flares. Hydrocortisone, when administered through a suppository, reduces inflammation of the anus, rectum, and sigmoid colon.

In summary, 5-ASA drugs for UC are associated with mostly mild gastrointestinal and neurological symptoms, and serious adverse effects are uncommon but warrant urgent evaluation if they occur. It is essential to discuss potential side effects and treatment options with a healthcare provider to find the best course of action for managing UC symptoms.

1. Ulcerative colitis (UC) is an inflammatory bowel disease (IBD), shared in characteristics with Crohn's disease.
2. Despite UC being a persistent condition with no definitive cure, medical professionals can dispense various medications and treatments to control symptoms.
3. One popular treatment for UC is 5-aminosalicylic acid (5-ASA) drugs, like mesalamine.
4. These drugs are anti-inflammatory and aid in reducing inflammation within the colon.
5. Side effects associated with 5-ASA drugs include nausea, abdominal pain, diarrhea, gas, bloating, mild stomach discomfort, headache, dizziness, fatigue, weakness, and fever.
6. Balsalazide, marketed under the name Colazal, is another medication for treating mild to moderate UC symptoms in individuals over 5 years old.
7. Aminosalicylates, another type of anti-inflammatory medication, are utilized to treat UC, with Sulfasalazine (Azulfidine) being an example.
8. Olsalazine is another medication used to maintain UC remission, particularly for those with sulfasalazine intolerance.
9. Corticosteroids, such as prednisone, are established treatments for IBD, offering temporary symptom relief, though not explicitly mentioned as a UC treatment in this article.
10. Corticosteroids can cause side effects, including increased infection susceptibility, weakened bones, insomnia, high blood pressure, high blood sugar, mood swings, cataracts, growth of facial hair, growth issues in children, weight gain, and a round or moon-shaped face.
11. Immunomodulators, like methotrexate, cyclosporine, azathioprine, 6-mercaptopurine, and tacrolimus, target IBD inflammation by managing the immune system's response.
12. Methylprednisolone is a corticosteroid delivered through an enema to reduce inflammation and lower side effect risks.
13. Hydrocortisone acetate, administered as a rectal foam, delivers medication to the colon and rectum, reducing inflammation.
14. Biologics, such as Tysabri (natalizumab) and Entyvio (vedolizumab), target proteins causing inflammation.
15. These biologics are integrin receptor antagonists and work by blocking proteins that trigger inflammation, like Stelara (ustekinumab), an interleukin-12 and -23 antagonist.
16. Potential side effects from biologics include a higher risk of infection, injection site pain or itching, allergic reactions, headache, fever, chills, rash, a higher lymphoma risk, liver problems, skin problems, joint pain, and more.
17. JAK inhibitors, such as Xeljanz (tofacitinib) and upadacitinib (Rinvoq), are a new treatment for UC using small molecule compounds targeting the immune system to reduce UC triggers.
18. However, JAK inhibitors may cause side effects such as upper respiratory tract infections, headache, diarrhea, shingles, blood clots, high cholesterol, and reactivated infections like hepatitis B and C.
19. Over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) can help relieve joint pain or fever from UC, but should be used with caution due to the potential risk of causing flares.
20. Hydrocortisone, when administered through a suppository, reduces inflammation of the anus, rectum, and sigmoid colon.
21. It is essential to weigh potential side effects and treatment choices with a healthcare provider to determine the best strategy for managing UC symptoms.
22. UC seekers should be aware of the various treatment options, including 5-ASA drugs, corticosteroids, immunomodulators, biologics, JAK inhibitors, and NSAIDs, to make informed decisions.
23. Treaters should be well-versed in understanding the various therapies and treatments for chronic diseases like UC.
24. While 5-ASA drugs are associated with mostly mild side effects, dangerous adverse events call for urgent evaluation.
25. The healthcare industry should work diligently to provide up-to-date information on various medical conditions, including UC, to ensure proper education for both treaters and patients.
26. Medicare plays an essential role in providing coverage for various UC treatments, allowing access to life-changing care.
27. CBD, a product derived from the cannabis plant, is becoming popular as an alternative treatment for various conditions, including UC, though more research is needed.
28. Environmental science has a role in understanding the possible links between climate change and chronic diseases like UC.
29. Mental health is crucial in managing chronic conditions like UC, with therapy and counseling playing significant roles in emotional wellbeing.
30. Skin care products can help manage various skin conditions that may arise from UC treatments.
31. Fitness and exercise can aid in managing UC symptoms by boosting overall health and wellness.
32. Good nutrition is essential in maintaining cardiovascular health and promoting digestive and eye health.
33. Hearing loss can occur as a result of certain UC treatments, so it is crucial to monitor hearing health.
34. In instances of severe or life-threatening UC symptoms, swift intervention from healthcare providers and emergency services is vital.

Read also: